A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years
Clinical trial NCT00909961 · COMPLETED
Trial details
- NCT number
- NCT00909961
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-12-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.